Robert's mailing address filed with the SEC is C/O ARAVIVE, INC., RIVER OAKS TOWER,, 3730 KIRBY DRIVE, SUITE 1200, HOUSTON, TX, 77098.
Over the last 6 years, insiders at Aravive Inc have traded over 107,045$ worth of Aravive Inc stock and bought 151,333 units worth 1,102,898$ . The most active insiders traders include Srinivas Akkaraju、Fredric N Eshelman Ventures...、Shahzad Malik. On average, Aravive Inc executives and independent directors trade stock every 75 days with the average trade being worth of 11,962$. The most recent stock trade was executed by Fredric N Eshelman Ventures... on 1 April 2022, trading 4,545,455 units of ARAV stock currently worth 181,818$.
versartis, inc. (nasdaq: vsar) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. the company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. versartis’ mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. learn more at www.versartis.com.
Aravive Inc executives and other stock owners filed with the SEC include: